LEONARD S JACOB Insider Trading $ATRS ANTARES PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LEONARD S JACOB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LEONARD S JACOB. LEONARD S JACOB is Director in ANTARES PHARMA, INC. ($ATRS) and Chairman and CEO in INKINE PHARMACEUTICAL CO INC ($INKP).
LEONARD S JACOB in ANTARES PHARMA, INC.
Trading Symbol: ATRSIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of LEONARD S JACOB: Director
Holdings: 268,363 shares
Current Value: $590,399
Latest Transaction: Feb 19 2021
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LEONARD S JACOB in ANTARES PHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 2.24 | 15,321 | 34,319 | 0 | |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 5.05 | 15,321 | 77,371 | 253,042 | 268.4 K to 253 K (-5.71 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 2.24 | 15,321 | 34,319 | 268,363 | 253 K to 268.4 K (+6.05 %) |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.73 | 77,662 | 212,017 | 77,662 | |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Grant | A | 2.73 | 40,293 | 110,000 | 253,042 | 212.7 K to 253 K (+18.94 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.66 | 80,000 | 132,800 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.60 | 80,000 | 128,000 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.63 | 84,814 | 392,833 | 212,749 | 297.6 K to 212.7 K (-28.50 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.62 | 80,000 | 369,776 | 297,563 | 377.6 K to 297.6 K (-21.19 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.66 | 80,000 | 132,800 | 377,563 | 297.6 K to 377.6 K (+26.89 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.63 | 80,000 | 370,536 | 297,563 | 377.6 K to 297.6 K (-21.19 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.60 | 80,000 | 128,000 | 377,563 | 297.6 K to 377.6 K (+26.89 %) |
Nov 04 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.10 | 20,000 | 22,000 | 0 | |
Nov 04 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.10 | 20,000 | 22,000 | 297,563 | 277.6 K to 297.6 K (+7.21 %) |
Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.92 | 73,431 | 214,419 | 73,431 | |
Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Grant | A | 2.92 | 37,671 | 109,999 | 277,563 | 239.9 K to 277.6 K (+15.70 %) |
Apr 10 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.53 | 30,000 | 15,900 | 0 | |
Apr 10 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.53 | 62,078 | 32,901 | 0 | |
Apr 10 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 3.00 | 92,078 | 276,243 | 239,892 | 332 K to 239.9 K (-27.74 %) |
Apr 10 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.53 | 30,000 | 15,900 | 331,970 | 302 K to 332 K (+9.93 %) |
Apr 10 2019 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.53 | 62,078 | 32,901 | 301,970 | 239.9 K to 302 K (+25.88 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.70 | 153,097 | 413,362 | 153,097 | |
Apr 02 2018 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.85 | 32,407 | 27,546 | 0 | |
Apr 02 2018 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.85 | 32,407 | 27,546 | 239,892 | 207.5 K to 239.9 K (+15.62 %) |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.50 | 188,600 | 94,300 | 0 | |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 0.85 | 30,000 | 25,500 | 0 | |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.05 | 200,000 | 810,420 | 207,485 | 407.5 K to 207.5 K (-49.08 %) |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.50 | 188,600 | 94,300 | 407,485 | 218.9 K to 407.5 K (+86.16 %) |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 4.05 | 30,000 | 121,500 | 218,885 | 248.9 K to 218.9 K (-12.05 %) |
Oct 11 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 0.85 | 30,000 | 25,500 | 248,885 | 218.9 K to 248.9 K (+13.71 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.66 | 160,636 | 427,292 | 160,636 | |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.65 | 21,762 | 35,907 | 0 | |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.65 | 20,000 | 33,000 | 21,762 | |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.90 | 21,762 | 63,112 | 218,885 | 240.6 K to 218.9 K (-9.04 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.65 | 21,762 | 35,907 | 240,647 | 218.9 K to 240.6 K (+9.94 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.88 | 20,000 | 57,570 | 218,885 | 238.9 K to 218.9 K (-8.37 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.65 | 20,000 | 33,000 | 238,885 | 218.9 K to 238.9 K (+9.14 %) |
Dec 05 2016 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.23 | 20,000 | 24,600 | 0 | |
Dec 05 2016 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 1.97 | 20,000 | 39,416 | 218,885 | 238.9 K to 218.9 K (-8.37 %) |
Dec 05 2016 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.23 | 20,000 | 24,600 | 238,885 | 218.9 K to 238.9 K (+9.14 %) |
Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 1.12 | 300,000 | 336,000 | 300,000 | |
Mar 21 2016 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | P | 0.72 | 50,000 | 36,000 | 218,885 | 168.9 K to 218.9 K (+29.61 %) |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.18 | 198,789 | 433,360 | 198,789 | |
Mar 24 2015 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.68 | 19,100 | 51,188 | 168,885 | 188 K to 168.9 K (-10.16 %) |
Mar 24 2015 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.69 | 4,400 | 11,836 | 187,985 | 192.4 K to 188 K (-2.29 %) |
Page: 1